MCF-7 Cells
USUSD$395.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
Essential facts about the MCF7 breast cancer cell line
| 說明 | MCF7 cells, a widely used research model in human breast cancer research, are utilized extensively as an in vitro model for hormone-dependent breast cancer. Originating from the breast tissue of a 69-year-old white female with metastatic adenocarcinoma, MCF7 cells are a widely used in vitro model for hormone-dependent breast cancer, reflecting the Luminal A subtype. This subtype is characterized by a lower grade and better prognosis compared to more aggressive forms of breast cancer. In the realm of breast cancer research, MCF 7 cells are instrumental in evaluating the efficacy of breast cancer drugs and understanding the dynamics of breast cancer stem cells. They are central to cancer research, serving as a comparative model against more aggressive cell lines like MDA-MB-231. The investigation of therapeutic agents, such as tamoxifen and doxorubicin, is critical in drug discovery efforts targeting hormone-dependent breast cancers and gaining insights into the mechanisms of action and resistance. Similarly, the role of estradiol in modulating the growth and characteristics of these cells is a subject of significant interest, given its relevance to hormone-responsive breast cancers. Research employing the MCF7 breast cancer cell line often delves into the cellular processes of cytotoxicity and apoptosis, especially in response to cancer agents like curcumin, known for its potential in cancer prevention. The study of immune responses, including the action of tumor necrosis factor alpha (TNF alpha) and the impact of bacterial antigens, further enriches our understanding of the tumor microenvironment and potential therapeutic targets. MCF7 cells are meticulously studied in both 2D cell culture and 3D cell culture systems, including spheroid culture, to mimic tumor microenvironments more closely. These methodologies enable a more profound exploration of cell spheroid growth and the behavior of cancer stem cells within microtissues in scaffold-based systems. The MCF7 cell line, with its epithelial cell characteristics and resemblance to human adenocarcinoma cells, is a cornerstone of cancer research. It facilitates not only the exploration of breast cancer drugs and their mechanisms but also the broader implications for cancer treatment, including the potential role of mesenchymal stem cells and the efficacy of targeted therapies in vivo studies. |
|---|---|
| 生物體 | Human |
| 組織 | Breast |
| 疾病 | Adenocarcinoma |
| 轉移部位 | Pleural effusion |
| 同義詞 | MCF 7, MCF.7, MCF7, Michigan Cancer Foundation-7, ssMCF-7, ssMCF7, MCF7/WT, MCF7-CTRL, IBMF-7 |
Features
| 年齡 | 69 years |
|---|---|
| 性別 | Female |
| 族裔 | Caucasian |
| 形態學 | Epithelial-like |
| 生長特性 | Monolayer, adherent |
Documentation
| 引用 | MCF-7 (Cytion catalog number 300273) |
|---|---|
| 生物安全等級 | 1 |
| NCBI_TaxID | 9606 |
| Cellosaurus 編號 | CVCL_0031 |
Genetic profile
| 受體的表達 | The cells express the wildtype and variant estrogen receptors as well as progesterone receptor. |
|---|---|
| 蛋白質表達 | P53 negative, pGP9.5 negative, CEA positive |
| 同工酶 | PGM3, 1, PGM1, 1-2, ES-D, 1-2, AK-1, 1, GLO-1, 1-2, G6PD, B, |
| 致癌基因 | Wnt7h +, Tx-4 |
| 致瘤性 | Yes, in nude mice |
| 產品 | Insulin-like growth factor binding proteins (IGFBP) BP-2, BP-4, BP-5 |
| 突變譜 | TP53 wt |
| 核型分析 | The stemline chromosome numbers ranged from hypertriploidy to hypotetraploidy, with the 2S component occurring at 1%. There were 29 to 34 marker chromosomes per S metaphase, 24 to 28 markers occurred in at least 30% of cells, and generally one large submetacentric (M1) and 3 large subtelocentric (M2, M3, and M4) markers were recognizable in over 80% of metaphases. No DM were detected. Chromosome 20 was nullisomic and x was disomic. Phenotype Frequency Product: 0.0154 |
MCF7 cell culturing methods
| 培養基 | EMEM (MEM Eagle), w: 2 mM L-Glutamine, w: 2.2 g/L NaHCO3, w: EBSS (Cytion article number 820100a) |
|---|---|
| 營養補充品 | Supplement the medium with 10% FBS and 1% NEAA |
| 解離試劑 | Accutase |
| 倍增時間 | 24 hours |
| 傳代培養 | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| 播種密度 | 3 x 104 cells/cm2 |
| 流體更新 | 2 to 3 times per week |
| 解凍後的恢復 | Allow the cells to rest for 48 hours past thawing |
| 冷凍培養基 | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| 細胞解凍與培養 |
|
| 培養環境 | 37°C, 5% CO2, humidified atmosphere. |
| 運送條款 | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| 儲存條件 | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality control
| 不孕症 | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
分析證明書 (CoA)
| 批次編號 | 證書類型 | 日期 | 型號 |
|---|---|---|---|
| 300273-140125 | 分析證明書 | 23. May. 2025 | 300273 |
| 300273-200125 | 分析證明書 | 23. May. 2025 | 300273 |
| 300273-250823 | 分析證明書 | 23. May. 2025 | 300273 |
-
Related products
Related products